| Literature DB >> 28056979 |
Isaac Ghinai1, Jackie Cook2, Teddy Tun Win Hla3, Hein Myat Thu Htet1, Tom Hall2, Inke Nd Lubis4, Rosanna Ghinai5, Therese Hesketh3, Ye Naung6, Mya Mya Lwin6, Tint Swe Latt6, David L Heymann7, Colin J Sutherland4, Chris Drakeley2, Nigel Field8.
Abstract
BACKGROUND: The spread of artemisinin-resistant Plasmodium falciparum is a global health concern. Myanmar stands at the frontier of artemisinin-resistant P. falciparum. Myanmar also has the highest reported malaria burden in Southeast Asia; it is integral in the World Health Organization's plan to eliminate malaria in Southeast Asia, yet few epidemiological data exist for the general population in Myanmar.Entities:
Keywords: Artemisinin; Elimination; Malaria; Myanmar; Prevalence; Resistance; Risk factors; Serology; Transmission
Mesh:
Year: 2017 PMID: 28056979 PMCID: PMC5217255 DOI: 10.1186/s12936-016-1651-5
Source DB: PubMed Journal: Malar J ISSN: 1475-2875 Impact factor: 2.979
Fig. 1Study site with GPS points (circles) demarcating each village cluster
Demographic characteristics of study participants
| Study population | ||
|---|---|---|
| n | % | |
| Total | 1638 | 100 |
| Gender | ||
| Males | 752 | 45.9 |
| Female | 886 | 54.1 |
| Age | ||
| 0–5 | 163 | 9.9 |
| 6–15 | 324 | 19.8 |
| 16–25 | 255 | 15.6 |
| 26–50 | 550 | 33.6 |
| 51–100 | 346 | 21.1 |
| Ethnicity | ||
| Burmese | 1086 | 64.1 |
| Indian | 507 | 33.0 |
| Shan | 45 | 2.9 |
| Socioeconomic status | ||
| Lowest | 513 | 32.4 |
| Middle | 549 | 34.6 |
| Highest | 523 | 33.0 |
| Work in or visit forest | ||
| Yes | 671 | 41.0 |
| No | 967 | 59.0 |
| Household bed net ownership | ||
| Yes, universal coverage | 398 | 79.6 |
| No | 102 | 20.4 |
Prevalence of symptoms (fever) and specific Plasmodium species by PCR and serology
| n | Prevalence (95% CIs) | Proportion of current infection (%) | |
|---|---|---|---|
| Fever | 89 | 4.9 (3.5–7.1) | 3/89 (3.4%) |
| PCR | |||
| Any | 41 | 2.6 (1.5–4.3) | 100a |
| | 19 | (0.4–3.0) | 46.3 (28.7–59.1) |
| | 16 | (0.5–2.2) | 39.0 (21.9–51.3) |
| | 7 | 0.5 (0.1–2.0) | 17.1 (2.2–22.2) |
| | 1 | 0.04 (0.0–0.4) | 2.4 (0–7.08) |
| Seropositive | |||
| | 150 | 9.4 (6.0–15.0) | |
| | 50 | 3.1 (1.9–6.3) | |
aIncludes two mixed infections, one P. falciparum and P.vivax, one P. knowlesi and P. vivax, therefore total percentages may not equal 100%
Fig. 2Proportion of Plasmodium species identified in a our sample and b WHO reporting for Myanmar. Pf, P. falciparum; Pv, P. vivax; Pk, P. knowlesi. K13 Pf samples with K13 mutations (not available for WHO statistics). * 1 × Pf Pv, 1 × Pk Pv, 1 × P. malariae
Association between demographic and behavioural characteristics and exposure to P. falciparum in study participants
| Sero-positive (%) | Odds ratio (OR) | p value | Adjusted ORa | p value | Denominators | ||
|---|---|---|---|---|---|---|---|
| Un-weighted | Weighted | ||||||
| Gender | |||||||
| Female | 7.1 | 1.0 (baseline) | 1.0 | 862 | 871 | ||
| Male | 12.6 | 1.9 (1.3–2.8) | 0.004 | 2.1 (1.3–3.4) | 0.006 | 740 | 731 |
| Age | |||||||
| 0–5 years | 0.3 | 1.0 | 1.0 | 162 | 181 | ||
| 5–15 years | 3.1 | 9.0 (1.4–58.9) | 9.0 (1.3–64.8) | 311 | 292 | ||
| 15–25 years | 3.8 | 11.2 (1.6–81.5) | 12.0 (1.5–94.8) | 253 | 265 | ||
| 25–50 years | 13.0 | 42.7 (4.0–456.3) | 43.8 (3.8–506.3) | 541 | 544 | ||
| 50–100 years | 20.0 | 71.2 (6.4–796.3) | 0.014 | 71.3 (5.6–904.2) | 0.030 | 335 | 319 |
| Working in/visiting forests | |||||||
| No | 5.8 | 1.0 | 1.0 | 1454 | 1454 | ||
| Yes | 14.7 | 2.8 (1.5–5.1) | 0.002 | 1.0 (0.6–1.8) | 0.979 | 31 | 31 |
| Bed net ownership | |||||||
| Not universal coverage | 6.6 | 1.0 | 1.0 | 391 | 417 | ||
| Universal coverage | 11.0 | 1.8 (0.8–3.8) | 0.134 | 1.1 (0.5–2.5) | 0.760 | 1161 | 1145 |
| Socio-economic status | |||||||
| Low | 11.6 | 1.0 | 1.0 | 506 | 462 | ||
| Medium | 11.2 | 0.9 (0.6–1.5) | 0.9 (0.6–1.6) | 532 | 531 | ||
| Highest | 7.2 | 0.6 (0.4–0.9) | 0.035 | 0.6 (0.3–0.9) | 0.072 | 512 | 566 |
aAdjusted for: age, gender, forest exposure, ethnicity, bed net ownership and socio-economic status
Fig. 3a Profile likelihood plot investigating the most likely age at which a change in seroconversion rate (SCR) occurs in P. falciparum serological data and b Seroprevalence curve fitted to P. falciparum with a change in SCR at age 23
Fig. 4Seroprevalence curves for P. falciparum a males and b females. The data for males has been fitted with two serconversion rates (SCR), with a change at age 23, and the data for females has been fitted with a constant SCR